We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+53.66%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
+$698M
Cap. Flow
+$72.5M
Cap. Flow %
5.01%
Top 10 Hldgs %
21.33%
Holding
759
New
418
Increased
75
Reduced
55
Closed
163

Top Buys

Rank Stock Value
1
SE icon
Sea Limited
SE
+$13.2M
2
BABA icon
Alibaba
BABA
+$6.77M
3
UPS icon
United Parcel Service
UPS
+$4.23M
4
TMO icon
Thermo Fisher Scientific
TMO
+$4.19M
5
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$4.03M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$16.2M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$4.48M
3
ZM icon
Zoom
ZM
+$3.15M
4
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$2.84M
5
LYFT icon
Lyft
LYFT
+$2.67M

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.23%
2 Consumer Discretionary 3.12%
3 Healthcare 2.22%
4 Technology 1.03%
5 Industrials 0.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAN icon
426
PUT
Banco Santander
SAN
$212B
$343K 0.02%
+148,696
New +$325K
HOLX
427
DELISTED
Hologic
HOLX
$342K 0.02%
+6,000
New +$294K
XBI icon
428
State Street SPDR S&P Biotech ETF
XBI
$10.5B
$336K 0.02%
+3,000
New +$295K
GLD icon
429
SPDR Gold Trust
GLD
$147B
$335K 0.02%
+2,000
New +$323K
PFSI icon
430
CALL
PennyMac Financial
PFSI
$3.53B
$334K 0.02%
8,000
– –
AAL icon
431
American Airlines Group
AAL
$8.54B
$327K 0.02%
25,000
+15,000
+150% +$182K
BEN icon
432
Franklin Templeton
BEN
$16.9B
$315K 0.02%
+15,000
New +$283K
ICPT
433
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$311K 0.02%
+6,500
New +$502K
CLF icon
434
Cleveland-Cliffs
CLF
$7.07B
$304K 0.02%
+55,000
New +$267K
EPI icon
435
PUT
WisdomTree India Earnings Fund ETF
EPI
$1.96B
$300K 0.02%
15,000
-5,000
-25% -$91.1K
ZBH icon
436
Zimmer Biomet
ZBH
$18.7B
$298K 0.02%
+2,575
New +$297K
GEN icon
437
CALL
Gen Digital
GEN
$18.4B
$297K 0.02%
15,000
– –
EDIT icon
438
CALL
Editas Medicine
EDIT
$412M
$296K 0.02%
10,000
+5,000
+100% +$131K
PNC icon
439
CALL
PNC Financial Services
PNC
$94.6B
$295K 0.02%
2,800
– –
ZYNE
440
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$295K 0.02%
+87,600
New +$414K
TBCH
441
PUT
Turtle Beach Corp
TBCH
$223M
$294K 0.02%
+20,000
New +$206K
BCE icon
442
BCE
BCE
$21B
$292K 0.02%
+7,000
New +$288K
TROX icon
443
Tronox
TROX
$698M
$292K 0.02%
+40,500
New +$267K
ARYBU
444
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
$290K 0.02%
+25,000
New +$275K
AXP icon
445
American Express
AXP
$214B
$286K 0.02%
+3,000
New +$276K
DB icon
446
Deutsche Bank
DB
$73B
$286K 0.02%
+30,000
New +$232K
KPTI icon
447
CALL
Karyopharm Therapeutics
KPTI
$38.1M
$284K 0.02%
+1,000
New +$296K
IVR icon
448
CALL
Invesco Mortgage Capital
IVR
$703M
$281K 0.02%
+7,500
New +$258K
BALL icon
449
Ball Corp
BALL
$16.3B
$278K 0.02%
+4,000
New +$270K
SEDG icon
450
SolarEdge
SEDG
$2.12B
$278K 0.02%
+2,000
New +$245K
16 17
18
19 20

Similar funds

EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

SG3 Management's Q2 2020 Portfolio in Review

As of Q2 2020, SG3 Management held 759 positions worth $1.45B, up 93% from $748M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

SG3 Management deployed $72.5M of net new capital in Q2 2020, opening 418 new positions and adding to 75 existing holdings. Its largest new stake was Sea Limited: 183,000 shares worth $19.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 94% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $1.21M trimmed.

  • SG3 Management's largest Q2 2020 buy was Sea Limited: 183,000 shares worth $19.6M.
  • SG3 Management added most to PENN Entertainment in Q2 2020, an estimated $2.45M increase.
  • SG3 Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.21M.
  • SG3 Management fully exited Tesla in Q2 2020, selling an estimated $16.2M.
  • SG3 Management's ten largest holdings make up 21% of its $1.45B portfolio in Q2 2020.
  • SG3 Management opened 418 new positions and closed 163 in Q2 2020.
  • SG3 Management's portfolio value rose 93% quarter-over-quarter to $1.45B.

Based on SG3 Management's 13F filing for Q2 2020, filed 14 Aug 2020.